Literature DB >> 21864016

Thrombocytopenia in childhood malaria with special reference to P. vivax monoinfection: A study from Bikaner (Northwestern India).

Gajanand Singh Tanwar1, Punam Chand Khatri, Chandra Kumar Chahar, Ghanshyam Singh Sengar, Abhishek Kochar, Gayatri Tanwar, Shaifali Chahar, Nimish Khatri, Sheetal Middha, Jyoti Acharya, Sanjay Kumar Kochar, Deepak Pakalapati, Shilpi Garg, Ashis Das, Dhanpat Kumar Kochar.   

Abstract

Thrombocytopenia is commonly seen in Plasmodium vivax malaria, but its prognostic value has not been addressed in children. This prospective study included 676 admitted children of malaria [Plasmodium falciparum (Pf) monoinfection 262, Plasmodium vivax (Pv) monoinfection 380, and mixed (Pf + Pv) infection 34], in which thrombocytopenia (platelet count <150 × 10(3)/mm(3) on admission) was found in 442 (65.38%) children [Pf monoinfection 55.3% (145/262), Pv monoinfection 73.16% (278/380), and mixed infection 55.88% (19/34)]. The association of thrombocytopenia was statistically significant with Pv monoinfection [73.16% (278/380)] in comparison to either Pf monoinfection [55.34% (145/262); odds ratio (OR) = 2.199 (95% confidence interval (CI) 1.577-3.068), p < 0.0001] or mixed infection [55.88% (19/34); OR = 2.152 (95%CI 1.054-4.394), p = 0.032]. In Pv monoinfection, thrombocytopenia was highest in 0-5 years age group and subsequently decreased with advancing age, whereas in Pf monoinfection it was reverse. Severe thrombocytopenia (platelet count <20 × 10(3)/mm(3)) was present in 16.52% (73/442) children [Pv monoinfection 21.58% (60/278) and Pf monoinfection 8.97% (13/145)]. The risk of developing severe thrombocytopenia was also highest in Pv monoinfection [15.79% (60/380)] in comparison to Pf monoinfection [10.59% (13/262); OR = 3.591 (95%CI 1.928-6.690), p < 0.0001]. Bleeding manifestations were associated in 21.27% (94/442) children [Pf monoinfection 9.92% (26/262), Pv monoinfection 16.58% (63/380), and mixed malaria 14.71% (5/34)]. All the children having bleeding manifestations had thrombocytopenia but low platelet counts were not always associated with abnormal bleeding. The association of severe malaria was significantly more among children having Pv monoinfection with platelet counts <20 × 10(3)/mm(3) [OR = 2.569 (95%CI 1.196-5.517), p < 0.014] with specificity of 88.3% and positive predictive value of 85%. Till today, thrombocytopenia is not included in severe malaria criterion described by WHO, but when platelet counts <20 × 103/mm(3), we advocate it to include as one of the severe malaria criteria.

Entities:  

Mesh:

Year:  2011        PMID: 21864016     DOI: 10.3109/09537104.2011.607520

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  15 in total

1.  Unusual presentation of Plasmodium vivax: a neglected human malaria parasite.

Authors:  Vivek B Kute; Jitendra G Goswami; Aruna V Vanikar; Pankaj R Shah; Manoj R Gumber; Himanshu V Patel; Kamal V Kanodia; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

2.  Influence of Plasmodium vivax malaria on the relations between the osmotic stability of human erythrocyte membrane and hematological and biochemical variables.

Authors:  Rita de Cássia Mascarenhas Netto; Camila Fabbri; Mariana Vaini de Freitas; Morun Bernardino Neto; Mário Silva Garrote-Filho; Marcus Vinícius Guimarães Lacerda; Emerson Silva Lima; Nilson Penha-Silva
Journal:  Parasitol Res       Date:  2013-12-10       Impact factor: 2.289

3.  Thrombocytopenia in children with vivax malaria: a study from north India.

Authors:  Chandra Mohan Kumar; Shweta Singh; Rajnish Garg
Journal:  Indian J Pediatr       Date:  2013-12-11       Impact factor: 1.967

4.  Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia.

Authors:  Fernanda M F Campos; Marina L S Santos; Flora S Kano; Cor J F Fontes; Marcus V G Lacerda; Cristiana F A Brito; Luzia H Carvalho
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

5.  Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India.

Authors:  Virender Kumar Gehlawat; Vandana Arya; Jaya Shankar Kaushik; Geeta Gathwala
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

6.  Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies.

Authors:  Rupesh Kumar Tyagi; Yagya Dutta Sharma
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

7.  Thrombocytopenia in Plasmodium vivax Malaria: How Significant?

Authors:  Arti Muley; Jitendra Lakhani; Saurabh Bhirud; Abhinam Patel
Journal:  J Trop Med       Date:  2014-06-17

8.  Clinical profile of malaria at a tertiary care teaching hospital in North India.

Authors:  Ritu Karoli; Shobhit Shakya; Nikhil Gupta; Vineeta Mittal; Anil Kumar Upadhyay
Journal:  Trop Parasitol       Date:  2021-05-14

9.  Thrombocytopenia in Plasmodium vivax malaria is related to platelets phagocytosis.

Authors:  Helena Cristina C Coelho; Stefanie C P Lopes; João Paulo D Pimentel; Paulo A Nogueira; Fábio T M Costa; André M Siqueira; Gisely C Melo; Wuelton M Monteiro; Adriana Malheiro; Marcus V G Lacerda
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Comparison of Clinical Profile between P. vivax and P. falciparum Malaria in Children: A Tertiary Care Centre Perspective from India.

Authors:  Jagdish Prasad Goyal; Aarti M Makwana
Journal:  Malar Res Treat       Date:  2014-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.